New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly ...
New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...
If you’ve noticed you’re getting winded faster, wheezing or coughing more, doctors say, don’t ignore it. Chronic obstructive ...
Regulatory officials have granted Molbreevi priority review and assigned a goal date of Aug. 22, 2026. If approved, Molbreevi will be priced between $400,000 and $500,000 per year.
After a 3-hour flight, however, he developed dyspnea and leg edema, and CT pulmonary angiography confirmed acute PE. He was started on rivaroxaban (Xarelto); but while taking it, he experienced ...
A phase 3 study of Gossamer Bio’s seralutinib in pulmonary arterial hypertension (PAH) has missed its primary endpoint, triggering a 77% crash in the biotech’s share price. The company has paused ...
A European study finds hospitalisations and insufficient growth reduce health-related quality of life in childhood ...
Gossamer Bio's experimental treatment failed to significantly improve exercise capacity in patients with a rare lung ...
MUSC Health has become the first site in South Carolina to offer balloon angioplasty to people with disabling symptoms from ...
O’Hara’s sudden passing on January 30 at age 71 has drawn attention to a medical emergency that can unfold rapidly. What ...
Stanford Medicine researchers claim they've created a "universal" that can protect against a viruses ranging from COVID to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results